Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 3
2012 2
2013 2
2014 3
2015 3
2016 1
2017 1
2018 3
2019 5
2020 4
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma.
Capparelli C, Purwin TJ, Glasheen M, Caksa S, Tiago M, Wilski N, Pomante D, Rosenbaum S, Nguyen MQ, Cai W, Franco-Barraza J, Zheng R, Kumar G, Chervoneva I, Shimada A, Rebecca VW, Snook AE, Hookim K, Xu X, Cukierman E, Herlyn M, Aplin AE. Capparelli C, et al. Among authors: hookim k. Nat Commun. 2022 Mar 16;13(1):1381. doi: 10.1038/s41467-022-28801-y. Nat Commun. 2022. PMID: 35296667 Free PMC article.
CADM1 is a TWIST1-regulated suppressor of invasion and survival.
Hartsough EJ, Weiss MB, Heilman SA, Purwin TJ, Kugel CH 3rd, Rosenbaum SR, Erkes DA, Tiago M, HooKim K, Chervoneva I, Aplin AE. Hartsough EJ, et al. Among authors: hookim k. Cell Death Dis. 2019 Mar 25;10(4):281. doi: 10.1038/s41419-019-1515-3. Cell Death Dis. 2019. PMID: 30911007 Free PMC article.
Castleman Disease: An Uncommon Mass in the Retroperitoneum.
Glick L, Xu H, Han TM, HooKim K, Vogel A, Lallas CD. Glick L, et al. Among authors: hookim k. Urology. 2020 Feb;136:e12-e15. doi: 10.1016/j.urology.2019.11.034. Epub 2019 Dec 5. Urology. 2020. PMID: 31812578 No abstract available.
In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms.
Teh JLF, Cheng PF, Purwin TJ, Nikbakht N, Patel P, Chervoneva I, Ertel A, Fortina PM, Kleiber I, HooKim K, Davies MA, Kwong LN, Levesque MP, Dummer R, Aplin AE. Teh JLF, et al. Among authors: hookim k. Cancer Discov. 2018 May;8(5):568-581. doi: 10.1158/2159-8290.CD-17-0699. Epub 2018 Mar 1. Cancer Discov. 2018. PMID: 29496664 Free PMC article.
24 results